When Rachel Archer noticed a small pimple on her forehead, she thought nothing of it—having acne-prone skin, she was used to ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

Freida Gantt, diagnosed with a rare cancer, spent her life caring for others as a certified nursing assistant.

When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...

Tarlatamab improved PFS and OS over chemotherapy as second-line treatment in patients with SCLC in the phase 3 DeLLphi-304 trial.

Heiskanen L, Nissinen L, Siljamäki E, et al. C5aR1 Promotes invasion, metastasis, and poor prognosis in cutaneous squamous cell carcinoma. Am J Pathol. 2025;195 (6):1158-1171. doi:10.1016/j ...

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, making up about 80 to 85 percent of all cases. [1] It’s referred to as metastatic NSCLC when it has spread from the ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...

A 14-gene assay predicts chemotherapy benefit in early-stage non-small-cell lung cancer, improving 24-month disease-free ...

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone.

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

As the leading cause of cancer-related death, lung cancer remains a noteworthy hazard to human health. NSCLC is the most prevalent subtype, accounting ...